Intuitive Surgical Inc. (ISRG) Dividend History

Intuitive Surgical Inc. is a pioneer in robotic-assisted minimally invasive surgery. Founded in 1995, the company is best known for its da Vinci Surgical System, which enhances surgeons' capabilities during complex procedures across various medical fields. Intuitive Surgical's technology aims to improve patient outcomes, reduce trauma, and shorten recovery times. Its devices are widely used in hospitals and surgical centers globally.

1020 Kifer Road, Sunnyvale, CA, 94086
Phone: (408) 523-2100
Website: https://www.intuitive.com

Dividend History

Intuitive Surgical Inc. currently does not pay dividends

Company News

  • The global hernia repair devices market is projected to reach US$ 6.57 billion by 2033, driven by rising procedural volumes, technological advancements, and increasing adoption of minimally invasive techniques. Key trends include the shift towards mesh implants, competition between open and laparoscopic repair, and the growing use of robotic platforms and biologic/biosynthetic materials.

    GlobeNewswire Inc.
    Featured Companies: MDT TELA
  • Restore Robotics received FDA clearance to remanufacture Intuitive Surgical's da Vinci Xi Monopolar Scissors. However, analysts believe the impact on Intuitive Surgical will be limited, as reprocessing is not new and the company allows the use of FDA-cleared third-party instruments.

    Benzinga
    Featured Companies: MDT
  • The article discusses three stocks - Nvidia, Intuitive Surgical, and Microsoft - that have the potential to continue outperforming the market. It provides an analysis of each company's growth prospects and valuation.

    The Motley Fool
    Featured Companies: MSFT NVDA
  • Intuitive Surgical, the leading developer of robotic surgical systems, reported strong Q4 2024 results with 18% growth in da Vinci procedure volume. However, the company expects a slowdown in procedure volume growth to 13-16% in 2025.

    Investing.com
    Featured Companies: MDT ZBH
  • Intuitive Surgical is a leading innovator in robotic-assisted surgery with its da Vinci Surgical System. The company benefits from an aging population and a solid competitive moat, making it a strong buy recommendation.

    Zacks Investment Research
Page data last updated 07/05/2025 02:02:20 UTC